Catabasis Pharmaceuticals Inc. (CATB) Surged 5.41% or 0.42 To Price $8.19 On Tuesday


Catabasis Pharmaceuticals Inc. (CATB) surged 5.41% or 0.42 to $8.19. It is approximately 83604 shares traded, which is 59.24% compare to the average total volume 141134. The market cap of CATB is $94.17 million. The year to date change is 80.8%. The 52 week price range is from $3.6 to $17.6. Price of CATB have changed -1.77% during last week. It have changed -6.16% over last month, 70.39% over last 3 months, 33.97% over last 6 months and -52.33% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CATB is 7.74. It is -5.49% below current price. The 200-day Moving Averages for CATB is 6.64. It is -18.93% below current price. The 52-week High is 17.6. It is 114.90% from the current price. The 52-week Low is 3.6. It is -56.04% from current price.

There are some statistics of CATB. It is has market cap $94.17 million. The share outstanding is 11.50 million. The average volume is 141134. The percent of top 15 Institution holding is 42.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CATB is -78.69%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CATB is -68.18%.


Tags:

Share this post